Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. - Wikidata - wikimedia - TriplyDB

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.

http://www.wikidata.org/entity/Q36510757

about

The SPLIT research agenda 2013 The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastoma Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium Hepatoblastoma clinical research: lessons learned and future challenges The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.Effective strategy of the combination of high-intensity focused ultrasound and transarterial chemoembolization for improving outcome of unresectable and metastatic hepatoblastoma: a retrospective cohort study.Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and serum alpha-fetoprotein kinetics.The treatment of hepatoblastoma: Its evolution and the current status as per the SIOPEL trials.Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy.Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group.Primary malignant liver tumors in children.Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies.Current and future management strategies for relapsed or progressive hepatoblastoma.Current chemotherapeutic approaches for hepatoblastoma.Death Within 1 Month of Diagnosis in Childhood Cancer: An Analysis of Risk Factors and Scope of the Problem.Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT).Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.

P2860

Q26825184-5B9E0636-19F2-459D-A200-10682B1A69BE Q26827928-7E3DEF99-0338-4A1D-BE3C-466F2F758E86 Q26828479-89B1B379-CF25-4A02-8363-91EBFBD9003A Q28268411-4AFBA220-73B2-4A71-820A-511B6078B073 Q28589033-66734F59-0ECE-4E5C-9E16-4F8C1B69A663 Q30274739-0969146F-CFA2-4A4D-815A-F00D633D9821 Q30418825-032A34DE-F062-4789-922F-0A83442CA2B9 Q33408942-5ABB7EFA-4443-4551-B29A-C91CF1E2F5DF Q33782216-A81AEF68-2AC0-4CA4-9A1E-8452C00AC903 Q34376509-AC22625E-E6EB-40F7-A9C9-945B653DB8CF Q35172214-23C79D92-15A2-438A-9DC8-B3D163CA4B80 Q36022690-97A7FC11-5DB1-420A-A9B1-BEE7C9E80D51 Q37075671-77FB11B7-292D-433A-BCAD-9E25FF2E0B5D Q37480824-5186A052-F163-4A4C-9D19-F24F9AF2F61A Q37989814-ED4AEE7B-39F6-4691-98D6-A002C7EF8B2D Q38014796-F28E6361-2507-4CBB-B713-91FA178E66D1 Q38019027-68A934F8-990A-4CC1-9565-901DFD441879 Q38139851-97EC80BE-25A4-4D06-939B-15C5B71069EC Q38834356-AE87F0BD-B867-4CCC-9BA6-DE65D53F897B Q38880725-760033F3-E295-498F-BBAB-9070B6CE4DF0 Q39155861-AC0930CD-EA0F-4DE4-BC27-12EBC19CC572 Q39351897-0F3FA26B-EB69-48DC-B7DB-4ED9B02243E3 Q41542757-7F6012CE-7246-45D2-8F5D-EE4F8779A1F4 Q53065628-891D4BB8-2D69-48BA-94E6-190A42521EBE

P2860

Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.

http://www.wikidata.org/entity/Q36510757

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Intensified platinum therapy i ...... with advanced hepatoblastoma.

@ast

Intensified platinum therapy i ...... with advanced hepatoblastoma.

@en

type

label

Intensified platinum therapy i ...... with advanced hepatoblastoma.

@ast

Intensified platinum therapy i ...... with advanced hepatoblastoma.

@en

prefLabel

Intensified platinum therapy i ...... with advanced hepatoblastoma.

@ast

Intensified platinum therapy i ...... with advanced hepatoblastoma.

@en

P1433

Q36510757-A89C72E1-3215-400F-BA89-C8C91CF08A96

P1476

Q36510757-59058B64-301C-4946-9D23-F1C941FDDFF1

P2093

Q36510757-09CEC631-F70A-45B5-9704-FFD88F9A7545

Q36510757-2F1ECD91-C730-46F7-92CB-C10BC2DC0A83

Q36510757-3A764100-33E7-4033-92FF-671209265BDB

Q36510757-4DAD0CD2-1393-410B-9FF7-808769A9BF7B

Q36510757-5193E1D0-7F79-4627-8E4E-EDBE71644205

Q36510757-5817BE38-DF3E-4495-9936-EE38BFC41B1F

Q36510757-65D16191-744C-4035-BDE0-7FFE23C0AAD5

Q36510757-6AF27388-C2D3-43A5-866F-7835D754FCDB

Q36510757-7FDEE8CE-D057-4231-8AA8-42768787F20C

Q36510757-8FCBDDF7-199C-4CEF-B9C5-2B1DDAEEB368

P304

Q36510757-69EF5773-4BA3-4619-B301-E57B9BC8545E

P31

Q36510757-7D1774FE-2AFD-437F-A390-F05638AF28F1

P356

Q36510757-3AFBDA48-1EB6-40CD-8113-4A6C81E07E25

P407

Q36510757-538C7C81-D6F0-41CB-A66F-0B50CB93EF93

P433

Q36510757-75F2FEB5-C654-4398-A558-03F5C129DB81

P478

Q36510757-79678596-8DD6-4F9D-A4F4-1525DC84B203

P577

Q36510757-DED89999-F863-4D6B-92AA-82749D285C89

P698

Q36510757-8EAB808D-4A4A-47B0-9749-41F1C925F776

P356

JCO.2005.02.6013

P1433

Journal of Clinical Oncology

P1476

Intensified platinum therapy i ...... with advanced hepatoblastoma.

@en

P2093

Brian Greffe

http://www.w3.org/2001/XMLSchema#string

Howard Katzenstein

http://www.w3.org/2001/XMLSchema#string

Jon Rowland

http://www.w3.org/2001/XMLSchema#string

Kurt Newman

http://www.w3.org/2001/XMLSchema#string

Laura Bowman

http://www.w3.org/2001/XMLSchema#string

Marcio H Malogolowkin

http://www.w3.org/2001/XMLSchema#string

Mark D Krailo

http://www.w3.org/2001/XMLSchema#string

Marleta Reynolds

http://www.w3.org/2001/XMLSchema#string

Milton Finegold

http://www.w3.org/2001/XMLSchema#string

Richard B Womer

http://www.w3.org/2001/XMLSchema#string

P304

2879-2884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.02.6013

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16782927

http://www.w3.org/2001/XMLSchema#string